Home/Filings/4/0001209191-16-138420
4//SEC Filing

Spring Bank Pharmaceuticals, Inc. 4

Accession 0001209191-16-138420

CIK 0001566373operating

Filed

Aug 22, 8:00 PM ET

Accepted

Aug 23, 8:43 PM ET

Size

4.5 KB

Accession

0001209191-16-138420

Insider Transaction Report

Form 4
Period: 2016-08-23
Freve Jonathan
CFO, Treasurer & Secretary
Transactions
  • Purchase

    Common stock

    2016-08-23$10.74/sh+1,000$10,7402,000 total

Issuer

Spring Bank Pharmaceuticals, Inc.

CIK 0001566373

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001566373

Filing Metadata

Form type
4
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 8:43 PM ET
Size
4.5 KB